SE8300320L - Anvendning av en saltlosning av monoklonala antikroppar med relativt hog salthalt vid blodgruppsbestemning - Google Patents

Anvendning av en saltlosning av monoklonala antikroppar med relativt hog salthalt vid blodgruppsbestemning

Info

Publication number
SE8300320L
SE8300320L SE8300320A SE8300320A SE8300320L SE 8300320 L SE8300320 L SE 8300320L SE 8300320 A SE8300320 A SE 8300320A SE 8300320 A SE8300320 A SE 8300320A SE 8300320 L SE8300320 L SE 8300320L
Authority
SE
Sweden
Prior art keywords
monoclonal antibodies
application
blood group
group determination
relative high
Prior art date
Application number
SE8300320A
Other languages
English (en)
Other versions
SE8300320D0 (sv
SE434680B (sv
Inventor
Karl Arne Lundblad
Original Assignee
Karl Arne Lundblad
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=20349708&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SE8300320(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Karl Arne Lundblad filed Critical Karl Arne Lundblad
Priority to SE8300320A priority Critical patent/SE434680B/sv
Publication of SE8300320D0 publication Critical patent/SE8300320D0/sv
Priority to DE8484850009T priority patent/DE3485289D1/de
Priority to EP84850009A priority patent/EP0115476B1/en
Priority to AT84850009T priority patent/ATE69891T1/de
Priority to US06/570,264 priority patent/US4618486A/en
Priority to JP59008372A priority patent/JPH0654316B2/ja
Publication of SE8300320L publication Critical patent/SE8300320L/sv
Publication of SE434680B publication Critical patent/SE434680B/sv

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/80—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood groups or blood types or red blood cells
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/962—Prevention or removal of interfering materials or reactants or other treatment to enhance results, e.g. determining or preventing nonspecific binding
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/807—Apparatus included in process claim, e.g. physical support structures
    • Y10S436/808—Automated or kit
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/826—Additives, e.g. buffers, diluents, preservatives

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Pathology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
SE8300320A 1983-01-21 1983-01-21 Anvendning av en saltlosning av monoklonala antikroppar med relativt hog salthalt vid blodgruppsbestemning SE434680B (sv)

Priority Applications (6)

Application Number Priority Date Filing Date Title
SE8300320A SE434680B (sv) 1983-01-21 1983-01-21 Anvendning av en saltlosning av monoklonala antikroppar med relativt hog salthalt vid blodgruppsbestemning
DE8484850009T DE3485289D1 (de) 1983-01-21 1984-01-10 Monoklonalantikoerperabfassung fuer diagnostischen gebrauch.
EP84850009A EP0115476B1 (en) 1983-01-21 1984-01-10 Monoclonal antibody formulation for diagnostic use
AT84850009T ATE69891T1 (de) 1983-01-21 1984-01-10 Monoklonalantikoerperabfassung fuer diagnostischen gebrauch.
US06/570,264 US4618486A (en) 1983-01-21 1984-01-12 Monoclonal antibody formulation for diagnostic use
JP59008372A JPH0654316B2 (ja) 1983-01-21 1984-01-20 診断用モノクロナル抗体製剤

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE8300320A SE434680B (sv) 1983-01-21 1983-01-21 Anvendning av en saltlosning av monoklonala antikroppar med relativt hog salthalt vid blodgruppsbestemning

Publications (3)

Publication Number Publication Date
SE8300320D0 SE8300320D0 (sv) 1983-01-21
SE8300320L true SE8300320L (sv) 1984-07-22
SE434680B SE434680B (sv) 1984-08-06

Family

ID=20349708

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8300320A SE434680B (sv) 1983-01-21 1983-01-21 Anvendning av en saltlosning av monoklonala antikroppar med relativt hog salthalt vid blodgruppsbestemning

Country Status (6)

Country Link
US (1) US4618486A (sv)
EP (1) EP0115476B1 (sv)
JP (1) JPH0654316B2 (sv)
AT (1) ATE69891T1 (sv)
DE (1) DE3485289D1 (sv)
SE (1) SE434680B (sv)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4764465A (en) * 1984-04-26 1988-08-16 Cetus Corporation Human monoclonal antibody against group A red blood cells
DE3686474T2 (de) * 1985-10-11 1993-02-11 Abbott Lab Diagnostische probe.
US4695553A (en) * 1985-11-01 1987-09-22 Becton Dickinson And Co., Inc. Method for increasing agglutination of groups of cells to produce improved cell layer interface in centrifuged blood sample using antibodies
US4837170A (en) * 1986-01-20 1989-06-06 Otsuka Pharmaceutical Co., Ltd. Monoclonal antibody, measuring method of glucosylated protein by utilizing the monoclonal antibody, and kit therefor
DE3901458A1 (de) * 1989-01-19 1990-07-26 Behringwerke Ag Verwendung von zwei- oder dreiwertigen kationen in immunchemischen tests
DE4035174A1 (de) * 1990-11-06 1992-05-07 Biotest Ag Verfahren zur bestimmung von proteinen in koerperfluessigkeiten und mittel zur durchfuehrung des verfahrens
US20030113316A1 (en) * 2001-07-25 2003-06-19 Kaisheva Elizabet A. Stable lyophilized pharmaceutical formulation of IgG antibodies
AU2003291689A1 (en) * 2002-10-31 2004-05-25 Protein Design Labs, Inc. Stable liquid pharmaceutical formulation of antibodies that are prone to isomerization
WO2005042743A2 (en) 2003-08-18 2005-05-12 Medimmune, Inc. Humanization of antibodies
US20070287196A1 (en) * 2004-06-11 2007-12-13 Adeka Corporation Enzymatic Modification of Cell-Surface H Antigen by Glycosyltransferases
AU2006227377B2 (en) 2005-03-18 2013-01-31 Medimmune, Llc Framework-shuffling of antibodies
WO2007002543A2 (en) 2005-06-23 2007-01-04 Medimmune, Inc. Antibody formulations having optimized aggregation and fragmentation profiles
WO2011029823A1 (en) 2009-09-09 2011-03-17 Novartis Ag Monoclonal antibody reactive with cd63 when expressed at the surface of degranulated mast cells
CN103154037A (zh) 2010-10-05 2013-06-12 诺瓦提斯公司 抗IL12Rβ1抗体及它们在治疗自身免疫病和炎性疾病中的用途
CU24300B1 (es) 2013-02-08 2017-12-08 Novartis Ag Anticuerpos anti-il-17a útiles en el tratamiento de trastornos autoinmunes e inflamatorios
EP3161001A2 (en) 2014-06-25 2017-05-03 Novartis AG Antibodies specific for il-17a fused to hyaluronan binding peptide tags
BR112018014150A2 (pt) 2016-01-11 2018-12-11 Novartis Ag anticorpos monoclonais humanizados imunoestimulantes contra interleucina-2 humana, e proteínas de fusão dos mesmos
US11773160B1 (en) 2022-08-05 2023-10-03 Anaveon AG Immune-stimulating IL-2 fusion proteins

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4164558A (en) * 1976-11-22 1979-08-14 Massachusetts Institute Of Technology Method for optimizing reagents for agglutination reactions
US4319882A (en) * 1980-02-21 1982-03-16 Yash Sharma Method for detecting immunological agglutination and biochemical agent therefor
WO1982003089A1 (en) * 1981-03-06 1982-09-16 Lennox Edwin Samuel Monoclonal antibody
WO1982003462A1 (en) * 1981-03-27 1982-10-14 Ltd Biospecia Immunological analysis and a biochemical agent therefore
EP0061541A1 (en) * 1981-03-27 1982-10-06 Biospecia Limited Immunological analysis and a biochemical agent therefor
GB2117789B (en) * 1982-03-29 1985-08-29 East Anglian Regional Health Abo blood grouping reagent
GB2127434A (en) * 1982-09-17 1984-04-11 Univ London A human monoclonal antibody against Rhesus D antigen

Also Published As

Publication number Publication date
JPH0654316B2 (ja) 1994-07-20
EP0115476B1 (en) 1991-11-27
US4618486A (en) 1986-10-21
SE8300320D0 (sv) 1983-01-21
ATE69891T1 (de) 1991-12-15
EP0115476A3 (en) 1988-10-12
JPS59138959A (ja) 1984-08-09
DE3485289D1 (de) 1992-01-09
EP0115476A2 (en) 1984-08-08
SE434680B (sv) 1984-08-06

Similar Documents

Publication Publication Date Title
SE8300320L (sv) Anvendning av en saltlosning av monoklonala antikroppar med relativt hog salthalt vid blodgruppsbestemning
GB1291631A (en) Triazolobenzodiazepine derivatives
ES8106407A1 (es) Procedimiento para el tratamiento de superficies hidrofobas
ATE81505T1 (de) Azacycloalkanderivate, absorptionspromotoren, die die derivate als effektiven inhaltsstoff enthalten und aeusserlich anzuwendende praeparate, die absorptionspromotoren enthalten.
ATE34077T1 (de) Hautbehandlungsmittel.
SE8400723L (sv) Farmaceutisk komposition
EP0131627A4 (en) SPECIFIC ANTIGENS OF THE CEA FAMILY (CARCINO-EMBRYONIC ANTIGEN), SPECIFIC ANTIBODIES OF THESE ANTIGENS AND THEIR METHODS OF USE.
ES8900068A1 (es) Procedimiento de dosificacion de anticuerpos dirigidos contra toxinas bacterianas.
KR850002399A (ko) 액체 서방출성 제형의 제조방법
ATE15604T1 (de) Biostimulierendes mittel.
BE848697A (fr) Reactif en solution stable pour la recherche de l'oxydase,
SU1163864A1 (ru) Способ определени антиэритроцитарных антител
GB1334884A (en) Aminoalcohols and their conversion to aminoketones
ATE80306T1 (de) Mittel zur absorptionsverbesserung von proteinen.
GB1463908A (en) 1-dimethylamino-methyl-6-substituted-4h-s-triazolo-4,3-a- 1,4-benzodiazepine
JPS5484026A (en) Aqueous solvent for agglutination test
UA11489A1 (uk) Спосіб визhачеhhя активhості тімозиhа
IE873143L (en) HOMOGENEOUS SHEEP TllTS AS AN INTERMEDIATE FOR THE¹PREPARATION OF HUMAN Tllts, AND THE USE THEREOF
JPS5379890A (en) N-substituted-bicyclic guanidines
JPS533579A (en) Preparation of ge-forming microbial cells
RU95106799A (ru) Диагностикум для определения ревматоидного фактора
JPS5229293A (en) Reagent for determination of alkali-phosphatase activity
GB1530942A (en) Method for the determination of pregnancy and a serodiagnostic composition therefor
ES8306259A1 (es) "procedimiento para la preparacion de toxoplasmas coloreados".
SE8303165D0 (sv) Foliebehallare for blodtransfusions- och infusionsendamal jemte forfarande for behallarens tillverkning samt for dess anvendning

Legal Events

Date Code Title Description
NAL Patent in force

Ref document number: 8300320-2

Format of ref document f/p: F

NUG Patent has lapsed

Ref document number: 8300320-2

Format of ref document f/p: F